![A Practical Approach for the Management of the Mixed Opioid Agonist- Antagonist Buprenorphine During Acute Pain and Surgery - Mayo Clinic Proceedings A Practical Approach for the Management of the Mixed Opioid Agonist- Antagonist Buprenorphine During Acute Pain and Surgery - Mayo Clinic Proceedings](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/33938c55-daed-4e73-aa36-84d17d4765d9/gr3_lrg.jpg)
A Practical Approach for the Management of the Mixed Opioid Agonist- Antagonist Buprenorphine During Acute Pain and Surgery - Mayo Clinic Proceedings
![Deciphering the molecular basis of the kappa opioid receptor selectivity: A Molecular Dynamics study - ScienceDirect Deciphering the molecular basis of the kappa opioid receptor selectivity: A Molecular Dynamics study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S109332632100111X-ga1.jpg)
Deciphering the molecular basis of the kappa opioid receptor selectivity: A Molecular Dynamics study - ScienceDirect
![The blocking of kappa‐opioid receptor reverses the changes in dorsolateral striatum dopamine dynamics during the amphetamine sensitization - Azocar - 2019 - Journal of Neurochemistry - Wiley Online Library The blocking of kappa‐opioid receptor reverses the changes in dorsolateral striatum dopamine dynamics during the amphetamine sensitization - Azocar - 2019 - Journal of Neurochemistry - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/d47b6fb7-e8b2-4af5-af57-9392445d2faf/jnc14612-fig-0005-m.png)
The blocking of kappa‐opioid receptor reverses the changes in dorsolateral striatum dopamine dynamics during the amphetamine sensitization - Azocar - 2019 - Journal of Neurochemistry - Wiley Online Library
Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor | Journal of Medicinal Chemistry
![Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists](https://www.frontiersin.org/files/Articles/447554/fphar-10-00407-HTML/image_m/fphar-10-00407-g001.jpg)
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
![Kappa opioid receptor signaling in the brain: Circuitry and implications for treatment | Semantic Scholar Kappa opioid receptor signaling in the brain: Circuitry and implications for treatment | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/b580128a9f89a98a08a72333526e0903627049c9/7-Figure1-1.png)
Kappa opioid receptor signaling in the brain: Circuitry and implications for treatment | Semantic Scholar
![A Narrative Pharmacological Review of Buprenorphine: A Unique Opioid for the Treatment of Chronic Pain | SpringerLink A Narrative Pharmacological Review of Buprenorphine: A Unique Opioid for the Treatment of Chronic Pain | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40122-019-00143-6/MediaObjects/40122_2019_143_Fig4_HTML.png)
A Narrative Pharmacological Review of Buprenorphine: A Unique Opioid for the Treatment of Chronic Pain | SpringerLink
Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist Chemotypes through a HTS and Hit Refinement Strategy | ACS Chemical Neuroscience
![Dynorphin/Kappa Opioid Receptor Signaling in Preclinical Models of Alcohol, Drug, and Food Addiction - ScienceDirect Dynorphin/Kappa Opioid Receptor Signaling in Preclinical Models of Alcohol, Drug, and Food Addiction - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0074774217301393-f03-01-9780128124734.jpg)
Dynorphin/Kappa Opioid Receptor Signaling in Preclinical Models of Alcohol, Drug, and Food Addiction - ScienceDirect
![Mixed Kappa/Mu Partial Opioid Agonists as Potential Treatments for Cocaine Dependence - ScienceDirect Mixed Kappa/Mu Partial Opioid Agonists as Potential Treatments for Cocaine Dependence - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-B978012420118700010X-f10-01-9780124201187.jpg)
Mixed Kappa/Mu Partial Opioid Agonists as Potential Treatments for Cocaine Dependence - ScienceDirect
![The Therapeutic Potential of κ-Opioids for Treatment of Pain and Addiction | Neuropsychopharmacology The Therapeutic Potential of κ-Opioids for Treatment of Pain and Addiction | Neuropsychopharmacology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnpp.2010.137/MediaObjects/41386_2011_Article_BFnpp2010137_Fig1_HTML.jpg)